Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Annual International Science of Team Science Conference
Novel Components of the mTORC1 and mTORC2 Pathways
Temperament and Developmental Psychopathology
Developmental Neuropsychology of Adhd
Quantum Dynamics of Ultracold Collisions and Reactions
Recently added grants:
Understanding mechanisms of transcriptional regulation by chromatin adaptor proteins
Role of B cell interactions in CNS autoimmune demyelination
Biochemical, structural and molecular dissection of androgen receptor transcriptional activity
Investigating cognitive-motor variability to predict driving performance in stroke survivors with MCI
Behavioral and Neural Target Engagement for ADHD Executive Working Memory Training
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35000-8-0-1
Application #
7579487
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/ Mayo Clinic, Rochester
$2,258,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Limburg, Paul J. /
$2,257,713
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant